Caplin Point Laboratories informs about press release

08 Mar 2023 Evaluate

Caplin Point Laboratories has informed that it enclosed Press Release regarding grant of USFDA approval for Abbreviated New Drug Application (ANDA) Thiamine Hydrochloride Injection USP, to its Subsidiary Caplin Steriles.

The above information is a part of company’s filings submitted to BSE.

Caplin Point Lab Share Price

2470.00 -110.05 (-4.27%)
09-Jan-2025 15:16 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1825.45
Dr. Reddys Lab 1372.05
Cipla 1487.30
Lupin 2253.20
Zydus Lifesciences 1009.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.